Difference between revisions of "The Future of R&D in Pharmaceutical Industry in 2025"

From ScenarioThinking
Jump to navigation Jump to search
Line 29: Line 29:
• [[Effect of development of health care system in emerging market countries to existing pharmaceutical industry]]<br>
• [[Effect of development of health care system in emerging market countries to existing pharmaceutical industry]]<br>
• [[Unification of regulatory approval]]<br>
• [[Unification of regulatory approval]]<br>
• [[Competitiveness through innovation in biotechnology]]<br>
• [[Increasing Competitiveness through innovation in biotechnology]]<br>
• [[New business models for pharmaceutical industry]]<br>
• [[Changing business models for pharmaceutical industry]]<br>
<br><br>''two more will be added''<br><br>
<br><br>''two more will be added''<br><br>
==Resources==
==Resources==


* [1] [http://www.nowandnext.com/?action=top_trend/list_trends&sectorId=10 Top Trends in Healthcare, Medicine and Pharmaceuticals]&nbsp;- What's Next
* [1] [http://www.nowandnext.com/?action=top_trend/list_trends&sectorId=10 Top Trends in Healthcare, Medicine and Pharmaceuticals]&nbsp;- What's Next
* [2] [http://www.jimcarroll.com/weblog/archives/000757.html 10 Major Healthcare / Pharmaceutical Trends]&nbsp;-Jim Carroll's Blog
* [2] [http://www.jimcarroll.com/weblog/archives/000757.html 10 Major Healthcare / Pharmaceutical Trends]&nbsp;-Jim Carroll's Blog

Revision as of 23:47, 17 September 2009